Pluristem stem cell therapy saves a patient, shares jump

(Reuters) - Pluristem Therapeutics Inc said a 7-year old girl suffering from a bone marrow disease experienced a reversal of her condition after receiving its experimental stem cell therapy, sending the Israeli company's shares up 32 percent.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/EA1VCZNKf_Y/us-pluristem-idUSBRE8480TO20120509

top news recent news save money travel make money best news